Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
2.
Cureus ; 14(9): e29010, 2022 Sep.
Article in English | MEDLINE | ID: mdl-36119001

ABSTRACT

Macular amyloidosis is a common type of primary localized cutaneous amyloidosis. We present a case report of a 74-year-old patient with no significant past medical history who was evaluated for dark macules and pruritus for over a year. On exam, follicular-based brown macules on the upper and lower back, bilateral shoulders, and bilateral dorsal upper arms were noted. The morphology and distribution of follicular-based macules was unusual, so the differential included follicular lichen planus, follicular eczema, and macular amyloidosis. Punch biopsy showed deposits of eosinophilic fibrillary material along with pigmentary incontinence in the papillary dermis, consistent with macular amyloidosis. Additionally, there was some trapping of the adnexal structures with atrophy of the periadnexal fat in the reticular dermis. In macular amyloidosis keratin, intermediate filaments such as cytokeratin serve as the amyloid precursors which deposit in the superficial dermis. Characteristically, macular amyloidosis presents as hyperpigmented macules or patches, often in a "rippled" linear pattern. This case highlights a rare presentation of macular amyloidosis because of the atypical follicular involvement and emphasizes the variety of presentations for localized cutaneous amyloidosis. Additionally, new treatment options such as Janus Kinase inhibitors and their potential role in the pathological pathway are discussed.

3.
Clin Dermatol ; 40(6): 788-791, 2022.
Article in English | MEDLINE | ID: mdl-35952855

ABSTRACT

Many dermatology residency programs adapted to the COVID-19 pandemic by transitioning to online teaching methods. This may impact the quality of education and the satisfaction of residents. Dermatology faculty and residents nationwide were surveyed regarding their experiences with the novel online curricula. A total of 65 individuals representing at least 20 ACGME-accredited dermatology programs responded. Many programs implemented a predominantly online curriculum (78%). Most participants reported that both clinical dermatology and dermatopathology were online during the pandemic's peak (90%). Among those who had experienced a live curriculum prior to the pandemic, 49% reported that a virtual curriculum had similar effectiveness, whereas 36% deemed it less effective. Open-ended questions suggested that disadvantages of a virtual curricula included too many distractions, lack of human features, and less spontaneous feedback. They also suggested advantages to an online curriculum included flexibility and more opportunities to hear from guest speakers. Dissatisfaction before the curriculum change was the same as after (7%), suggesting that the educational experience was not worsened. Failing to adjust the curriculum to residents' needs can contribute to lower satisfaction and inadequate education. The variation of responses signifies the importance of seeking sufficient feedback from residents to meet their educational needs.


Subject(s)
COVID-19 , Dermatology , Internship and Residency , Humans , Pandemics , Dermatology/education , COVID-19/epidemiology , Curriculum
4.
J Gen Intern Med ; 37(9): 2267-2279, 2022 07.
Article in English | MEDLINE | ID: mdl-35710666

ABSTRACT

Primary care physicians (PCPs) are often the first line of defense against skin cancers. Despite this, many PCPs do not receive a comprehensive training in skin conditions. Educational interventions aimed at skin cancer screening instruction for PCPs offer an opportunity to detect skin cancer at earlier stages and subsequent improved morbidity and mortality. A scoping review was conducted to collect data about previously reported skin cancer screening interventions for PCPs. A structured literature search found 51 studies describing 37 unique educational interventions. Curriculum elements utilized by the interventions were divided into categories that would facilitate comparison including curriculum components, delivery format, delivery timing, and outcome measures. The interventions varied widely in design, including literature-based interventions, live teaching sessions, and online courses with durations ranging from 5 min to 24 months. While several interventions demonstrated improvements in skin cancer knowledge and competency by written exams, only a few revealed positive clinical practice changes by biopsy review or referral analysis. Examining successful interventions could aid in developing a skin cancer detection curriculum for PCPs that can produce positive clinical practice and population-based changes in the management of skin cancer.


Subject(s)
Physicians, Primary Care , Skin Neoplasms , Curriculum , Early Detection of Cancer , Humans , Physicians, Primary Care/education , Primary Health Care , Referral and Consultation , Skin Neoplasms/diagnosis , Skin Neoplasms/therapy
6.
JAAD Case Rep ; 18: 64-66, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34825040
7.
Dermatol Online J ; 26(9)2020 Sep 15.
Article in English | MEDLINE | ID: mdl-33054935

ABSTRACT

Transient receptor potential vanilloid type 1 (TRPV1) is found on sensory neurons, keratinocytes, sebocytes, and dendritic cells. Activated TRPV1 channels are believed to help propagate the itch sensation. Therefore, there has been great interest in targeting TRPV1 to treat pruritus. Since oral formulations aimed at TRPV1 have led to adverse effects such as hyperthermia, there has been emphasis on developing novel topical agents. Several companies are investigating topical TRPV1 anti-pruritic compounds and the initial data has been very promising. These drugs have the potential to be important treatment options for the management of itch. This paper reviews topical products in current development for pruritus that target TRPV1 channels.


Subject(s)
Antipruritics/therapeutic use , Pruritus/drug therapy , TRPV Cation Channels/antagonists & inhibitors , Acrylamides/therapeutic use , Administration, Cutaneous , Clinical Trials as Topic , Heterocyclic Compounds, 4 or More Rings/therapeutic use , Humans , Pyridines/therapeutic use , Receptor, trkA/antagonists & inhibitors , Sodium Channel Blockers/therapeutic use
8.
Dermatol Online J ; 26(9)2020 Sep 15.
Article in English | MEDLINE | ID: mdl-33054940

ABSTRACT

Cutaneous non-tuberculous mycobacterial (NTM) infections have rapidly increased in incidence in recent years. Currently there is no standard treatment and the variable and nonspecific ways in which cutaneous NTM infection presents makes it a therapeutic and diagnostic challenge. We describe a 67-year-old immunocompetent woman with cutaneous NTM infection after she recently underwent a root canal procedure. Although the species was not identified and she was unable to tolerate multiple antibiotics, she ultimately responded well to three months of treatment with linezolid. Given that cutaneous NTM infection can present in immunocompetent patients and that the incidence is rising, it is important for clinicians to maintain a high index of clinical suspicion, especially in patients with a recent history of surgery, trauma, or cosmetic procedures. Linezolid has coverage against non-tuberculous mycobacteria and is an effective therapeutic option for cutaneous NTM cases in which identification to the species level is not possible or when adverse effects limit therapeutic options.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Linezolid/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Skin Diseases, Bacterial/drug therapy , Aged , Biopsy , Female , Humans , Mycobacterium Infections, Nontuberculous/pathology , Root Canal Therapy/adverse effects , Skin Diseases, Bacterial/pathology
10.
Dermatol Online J ; 26(12)2020 Dec 15.
Article in English | MEDLINE | ID: mdl-33423427

ABSTRACT

Acrokeratoelastoidosis (AKE) is a rare, benign papular keratoderma that presents as keratotic papules on the lateral margins of the palms and soles. It is most commonly inherited in an autosomal dominant fashion, although sporadic cases are also described. We present a sporadic case of AKE in an 11-year-old girl with a past medical history significant for asthma. On literature review, we found three other cases presenting in children with a past medical history of asthma. We suggest a possible association between asthma and sporadic cases of AKE in children. Current understanding of the pathophysiology of AKE and its associated risk factors is limited and no effective treatment exists. Awareness of a possible association with asthma and atopy, careful history recording in young patients presenting with sporadic cases of AKE, and further research may help to delineate the likelihood of an association between AKE and asthma or atopy. Developing a better understanding of the associated factors that may contribute to the disease process may help guide more effective, targeted treatments in the future.


Subject(s)
Asthma/complications , Keratoderma, Palmoplantar/complications , Adolescent , Child , Female , Humans , Keratoderma, Palmoplantar/pathology , Skin/pathology
12.
Dermatol Online J ; 25(10)2019 Oct 15.
Article in English | MEDLINE | ID: mdl-31735009

ABSTRACT

Hydroxyurea is a chemotherapeutic agent that is used in the treatment of various hematological diseases including chronic myelogenous leukemia, polycythemia vera, and sickle cell anemia. Hydroxyurea is also used to treat psoriasis. Drug-induced hyperpigmentation is a known cutaneous side effect of hydroxyurea along with xerosis, dermal ulcers, and dermatomyositis-like eruptions. Hyperpigmentation has been observed in the oral mucosa, nails, and in a generalized or a diffuse pattern. The mechanism of hyperpigmentation related to hydroxyurea is believed to be correlated with increased melanin. Classically, clinical types of diffuse hyperpigmentation owing to iron deposition in the dermis have been associated with minocycline and not with hydroxyurea. We report a novel case in which hydroxyurea hyperpigmentation is associated with iron deposition.


Subject(s)
Hydroxyurea/adverse effects , Hyperpigmentation/chemically induced , Iron/analysis , Nucleic Acid Synthesis Inhibitors/adverse effects , Skin/pathology , Aged , Humans , Hyperpigmentation/pathology , Male , Microscopy, Electrochemical, Scanning , Skin/chemistry
13.
Dermatol Online J ; 23(8)2017 Aug 15.
Article in English | MEDLINE | ID: mdl-29469740

ABSTRACT

Linear IgA bullous dermatosis is a rare autoimmune vesiculobullous disease characterized by linear deposition of IgA along the basement membrane zone. It is classically idiopathic, but may also arise secondary to drug exposure. A heterogeneous spectrum of clinical features has been described, including a rare, morbid variant mimicking toxic epidermal necrolysis. Herein, we present a case of vancomycin-induced linear IgA bullous dermatosis that manifested clinically as toxic epidermal necrolysis and resolved with dapsone therapy.


Subject(s)
Anti-Bacterial Agents/adverse effects , Linear IgA Bullous Dermatosis/diagnosis , Linear IgA Bullous Dermatosis/drug therapy , Stevens-Johnson Syndrome/diagnosis , Vancomycin/adverse effects , Anti-Infective Agents/therapeutic use , Dapsone/therapeutic use , Diagnosis, Differential , Humans , Linear IgA Bullous Dermatosis/chemically induced , Linear IgA Bullous Dermatosis/pathology , Male , Middle Aged
14.
Am J Trop Med Hyg ; 91(2): 345-7, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24865687

ABSTRACT

Cutaneous leishmaniasis is rarely seen in the United States. Four Cuban immigrants traveled along the same route at different times from Cuba to Ecuador, then northward, including through the Darién Jungle in Panama. These patients had chronic ulcerative non-healing skin lesions and were given a diagnosis of leishmaniasis.


Subject(s)
Emigrants and Immigrants , Leishmania guyanensis/physiology , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/parasitology , Adult , Amphotericin B/therapeutic use , Antiprotozoal Agents/therapeutic use , Cuba , Female , Humans , Leishmania guyanensis/drug effects , Leishmaniasis, Cutaneous/drug therapy , Male , Middle Aged , Panama , Travel , United States
15.
Pediatr Dermatol ; 31(1): e20-1, 2014.
Article in English | MEDLINE | ID: mdl-24118007

ABSTRACT

We report the case of a 16-year-old boy who presented to our clinic with concomitant hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum. Recent reports describe the co-occurrence of pyoderma gangrenosum, acne, and hidradenitis suppurativa. This case further expands the spectrum of concomitant pyoderma gangrenosum and dissecting cellulitis of the scalp.


Subject(s)
Cellulitis/complications , Hidradenitis Suppurativa/complications , Pyoderma Gangrenosum/complications , Scalp Dermatoses/complications , Skin Diseases, Genetic/complications , Adolescent , Axilla/pathology , Cellulitis/pathology , Cellulitis/therapy , Hidradenitis Suppurativa/pathology , Hidradenitis Suppurativa/therapy , Humans , Male , Pyoderma Gangrenosum/pathology , Pyoderma Gangrenosum/therapy , Scalp/pathology , Scalp Dermatoses/pathology , Scalp Dermatoses/therapy , Skin Diseases, Genetic/pathology , Skin Diseases, Genetic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...